Research and Markets: Psychosis - Pipeline Review, Q4 2010

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/3a2627/psychosis_pipeli) has announced the addition of Global Markets Direct's new report "Psychosis - Pipeline Review, Q4 2010" to their offering.

Psychosis Pipeline Review, Q4 2010, provides an overview of the Psychosis therapeutic pipeline. This report provides information on the therapeutic development for Psychosis , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Psychosis . Psychosis -Pipeline Review 2010, Q4 2010 is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources

Scope

  • A snapshot of the global therapeutic scenario for Psychosis .
  • A review of the Psychosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Psychosis pipeline on the basis of therapeutic class, route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Key Topics Covered:

  • List of Tables
  • List of Figures
  • Introduction
  • Global Markets Direct Report Coverage
  • Psychosis Overview
  • Therapeutics Development
  • An Overview of Pipeline Products for Psychosis
  • Psychosis Therapeutics under Development by Companies
  • Psychosis Therapeutics under Investigation by Universities/Institutes
  • Late Stage Products
  • Comparative Analysis
  • Mid Clinical Stage Products
  • Comparative Analysis
  • Early Clinical Stage Products
  • Comparative Analysis
  • Pre-Clinical Stage Products
  • Comparative Analysis
  • Companies Involved in Psychosis Therapeutics Development
  • and much more....

For more information visit http://www.researchandmarkets.com/research/3a2627/psychosis_pipeli

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager,
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716